RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $114.19
Change -$0.15 | -0.13%
As Of 4/17/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.


Net Asset Value

Net Asset Value $114.19
Change -$0.15 | -0.13%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Distributors, LLC.


Profile

Volume 14,197
Last Sale Price $114.37
52-Week Range $121.33 / $89.30
Shares Outstanding 1,650,000
Total Net Assets $188,414,044.57

Overall Morningstar RatingTM *

as of 12/31/13

Among Health Funds

As of 12/31/2013, this fund was rated, based on its risk-adjusted returns, 3 stars for 3 years, 4 stars for 5 years, and 4 stars Overall out of 19, 17 and 19 Health funds, respectively.

Market Close

Market Price $114.37
Premium / Discount $0.18
Change $0.01 | 0.01%
High / Low $114.57 / $113.67


Historical Market Closes to NAV

  Days % of Total Days
Premium 914 48.72%
Discount 858 45.74%
Equal to NAV 104 5.54%
Total 1,876 100%


Characteristics

Number of Stocks 54
Return on Equity (quarterly 3/31/14) 15.84%
Price to Earning (P/E) 30.16
Price to Book (P/B) 4.85
Dividend Amount $0.15
Ex-Dividend Date N/A

Risk

As of 3/31/14
Standard Deviation Sharpe Ratio Beta R-Squared
12.62 1.65 1.01 99.52

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.

Overview

as of 4/17/2014
Total Assets $188,414,045
Number of Stocks 54
Percent Stock 99.86%
Percent Cash / Other 0.14%

Sectors / Industries

as of 4/17/14

Holdings

as of 4/17/14

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
EDWARDS LIFESCIENCES CORP EW 49,637 $4,034,991.73 2.14% Health Care Equipment & Supplies
QUEST DIAGNOSTICS, INC. DGX 66,826 $3,974,810.48 2.11% Health Care Providers & Services
BAXTER INTERNATIONAL BAX 53,862 $3,921,692.22 2.08% Health Care Equipment & Supplies
JOHNSON & JOHNSON JNJ 38,588 $3,818,668.48 2.03% Pharmaceuticals
LABORATORY CORP OF AMERIC LH 37,442 $3,793,249.02 2.01% Health Care Providers & Services
BOSTON SCIENTIFIC CORP BSX 275,279 $3,757,558.35 1.99% Health Care Equipment & Supplies
ALLERGAN INC AGN 27,898 $3,736,100.16 1.98% Pharmaceuticals
ELI LILLY & COMPANY LLY 60,828 $3,675,836.04 1.95% Pharmaceuticals
DAVITA, INC DVA 52,519 $3,650,595.69 1.94% Health Care Providers & Services
HOSPIRA INC HSP 85,073 $3,644,527.32 1.93% Pharmaceuticals
MERCK & COMPANY, INC. MRK 64,301 $3,631,077.47 1.93% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 79,826 $3,607,336.94 1.91% Health Care Equipment & Supplies
UNITEDHEALTH GROUP INC. UNH 47,308 $3,585,000.24 1.90% Health Care Providers & Services
ABBOTT LABORATORIES ABT 91,895 $3,577,472.35 1.90% Health Care Equipment & Supplies
TENET HEALTHCARE CORP THC 89,979 $3,573,965.88 1.90% Health Care Providers & Services
PATTERSON COS INC PDCO 87,026 $3,571,547.04 1.90% Health Care Providers & Services
MEDTRONIC, INC. MDT 60,846 $3,562,533.30 1.89% Health Care Equipment & Supplies
COVIDIEN PLC COV 50,978 $3,561,323.08 1.89% Health Care Equipment & Supplies
PERKINELMER PKI 80,023 $3,542,618.21 1.88% Life Sciences Tools & Services
CIGNA CORPORATION CI 46,788 $3,539,044.32 1.88% Health Care Providers & Services
AGILENT TECHNOLOGIES, INC A 64,605 $3,530,663.25 1.87% Life Sciences Tools & Services
WELLPOINT, INC. WLP 38,356 $3,528,752.00 1.87% Health Care Providers & Services
WATERS CORPORATION WAT 31,678 $3,521,009.70 1.87% Life Sciences Tools & Services
STRYKER CORP SYK 44,623 $3,515,399.94 1.87% Health Care Equipment & Supplies
BECTON DICKINSON & CO BDX 31,049 $3,513,504.84 1.86% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 29,294 $3,494,774.20 1.85% Life Sciences Tools & Services
INTUITIVE SURGICAL, INC. ISRG 8,470 $3,489,555.30 1.85% Health Care Equipment & Supplies
ZOETIS INC ZTS 121,728 $3,481,420.80 1.85% Pharmaceuticals
PFIZER INC PFE 114,673 $3,468,858.25 1.84% Pharmaceuticals
ZIMMER HOLDINGS INC ZMH 38,033 $3,460,622.67 1.84% Health Care Equipment & Supplies
C.R. BARD, INC. BCR 24,710 $3,446,797.90 1.83% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 53,003 $3,428,234.04 1.82% Health Care Providers & Services
HUMANA, INC. HUM 32,715 $3,426,569.10 1.82% Health Care Providers & Services
CAREFUSION CORP CFN 88,994 $3,426,269.00 1.82% Health Care Equipment & Supplies
ST. JUDE MEDICAL INC. STJ 54,793 $3,424,014.57 1.82% Health Care Equipment & Supplies
VARIAN MEDICAL SYSTEMS IN VAR 42,510 $3,412,702.80 1.81% Health Care Equipment & Supplies
ABBVIE INC-W/I ABBV 69,924 $3,394,810.20 1.80% Pharmaceuticals
AETNA INC AET 50,083 $3,394,124.91 1.80% Health Care Providers & Services
CELGENE CORPORATION CELG 23,977 $3,392,985.27 1.80% Biotechnology
MCKESSON CORPORATION MCK 19,804 $3,386,087.92 1.80% Health Care Providers & Services
CARDINAL HEALTH, INC. CAH 49,547 $3,375,637.11 1.79% Health Care Providers & Services
AMGEN INC. AMGN 29,223 $3,374,087.58 1.79% Biotechnology
FOREST LABORATORIES, INC. FRX 37,496 $3,358,891.68 1.78% Pharmaceuticals
EXPRESS SCRIPTS HLDGS ESRX 46,289 $3,346,231.81 1.78% Health Care Providers & Services
GILEAD SCIENCES, INC. GILD 47,721 $3,340,470.00 1.77% Biotechnology
ACTAVIS PLC ACT 16,689 $3,294,241.71 1.75% Pharmaceuticals
BRISTOL MYERS SQUIBB CO BMY 66,325 $3,280,434.50 1.74% Pharmaceuticals
CERNER CORPORATION CERN 60,417 $3,262,518.00 1.73% Health Care Technology
REGENERON PHARMACEUTICALS REGN 10,870 $3,225,563.80 1.71% Biotechnology
MYLAN INC. MYL 68,044 $3,192,624.48 1.69% Pharmaceuticals
BIOGEN IDEC, INC. BIIB 10,780 $3,132,021.20 1.66% Biotechnology
PERRIGO CO PLC PRGO 21,648 $3,073,799.52 1.63% Pharmaceuticals
ALEXION PHARMACEUTICALS I ALXN 20,430 $3,060,414.00 1.62% Biotechnology
VERTEX PHARMACEUTICALS VRTX 45,732 $2,934,622.44 1.56% Biotechnology
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 89,562 $89,562.25 0.05% na

Disclosure

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
 

2014 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.